MASSACHUSETTS FINANCIAL SERVICES CO /MA/ - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 169 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.

Quarter-by-quarter ownership
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$1,240,022
-7.7%
195,279
-12.0%
0.00%
Q1 2024$1,344,150
+303.6%
221,807
+177.5%
0.00%
Q1 2022$333,000
-12.1%
79,942
+1.0%
0.00%
Q4 2021$379,000
-12.1%
79,123
-2.0%
0.00%
Q3 2021$431,000
+2.9%
80,725
-1.3%
0.00%
Q2 2021$419,000
-23.3%
81,784
+0.9%
0.00%
Q1 2021$546,000
+31.9%
81,084
-10.6%
0.00%
Q4 2020$414,000
-71.9%
90,695
+0.8%
0.00%
-100.0%
Q2 2018$1,475,00089,9330.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Fosun International Ltd 19,552,001$433,859,00020.80%
BRIDGER MANAGEMENT, LLC 2,642,621$58,640,0003.39%
TPG Group Holdings (SBS) Advisors, Inc. 3,884,600$86,199,0001.10%
HUSSMAN STRATEGIC ADVISORS, INC. 125,000$2,774,0000.80%
HealthCor Management, L.P. 1,036,110$22,991,0000.76%
GW&K Investment Management, LLC 2,049,765$45,484,0000.73%
Bridge City Capital, LLC 50,434$1,119,0000.70%
TCW GROUP INC 2,521,064$55,942,0000.46%
FRONTIER CAPITAL MANAGEMENT CO LLC 2,876,367$63,827,0000.41%
Quadrant Capital Management, LLC 25,002$555,0000.35%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders